Tiziana Life Sciences PLC (NASDAQ:TLSA) has seen 1.81 million shares traded in the last trading session. The company, currently valued at $188.09M, closed the last trade at $2.08 per share which meant it gained $0.08 on the day or 4.00% during that session. The TLSA stock price is -161.54% off its 52-week high price of $5.44 and 29.81% above the 52-week low of $1.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.78 million shares traded. The 3-month trading volume is 641.82K shares.
The consensus among analysts is that Tiziana Life Sciences PLC (TLSA) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Tiziana Life Sciences PLC (NASDAQ:TLSA) trade information
Sporting 4.00% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the TLSA stock price touched $2.08 or saw a rise of 0.95%. Year-to-date, Tiziana Life Sciences PLC shares have moved 2.97%, while the 5-day performance has seen it change 26.83%. Over the past 30 days, the shares of Tiziana Life Sciences PLC (NASDAQ:TLSA) have changed 1.96%. Short interest in the company has seen 0.11 million shares shorted with days to cover at 0.4.
Wall Street analysts have a consensus price target for the stock at $7.75, which means that the shares’ value could jump 73.16% from current levels. The projected low price target is $7.50 while the price target rests at a high of $8.00. In that case, then, we find that the current price level is -284.62% off the targeted high while a plunge would see the stock gain -260.58% from current levels.
Tiziana Life Sciences PLC (TLSA) estimates and forecasts
The company’s shares have lost -24.64% over the past 6 months, compared to 7.50% for the industry.
Tiziana Life Sciences PLC is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tiziana Life Sciences PLC (NASDAQ:TLSA)’s Major holders
Insiders own 0.00% of the company shares, while shares held by institutions stand at 13.25% with a share float percentage of 13.25%. Investors are also buoyed by the number of investors in a company, with Tiziana Life Sciences PLC having a total of 25 institutions that hold shares in the company. The top two institutional holders are Morgan Stanley with over 0.3 million shares worth more than $0.83 million. As of Mar 30, 2021, Morgan Stanley held 58.98% of shares outstanding.
The other major institutional holder is State Street Corporation, with the holding of over 0.21 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $0.57 million and represent 41.02% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are SPDR Portfolio Developed World ex-US ETF and Trust For Professional Managers-PMC Diversified Equity Fund. As of May 30, 2021, the former fund manager holds about 34.66% shares in the company for having 0.18 million shares of worth $0.41 million while later fund manager owns 54218.0 shares of worth $0.15 million as of Mar 30, 2021, which makes it owner of about 10.74% of company’s outstanding stock.